eli lilly clinical trials retatrutide Breaking: New trial data just released. TRIUMPH-1 study results on the triple agonist. Lilly's trial on Retatrutide (triple agonist compound). 80 weeks. Phase 3 data. The results: At 12mg VisualAbstract: Retatrutide reduces body weight
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

























